The publications on bacterial involvement in PMP by the research group are given below.

Semino-Mora C, Liu H, McAvoy T, Nieroda C, Studeman K, Sardi A, Dubois A., “Pseudomyxoma peritonei: is disease progression related to microbial agents? A study of bacteria, MUC2 AND MUC5AC expression in disseminated peritoneal adenomucinosis and peritoneal mucinous carcinomatosis”, Ann Surg Oncol., 15(5):1414-23, May 2008. Free pdf link

Semino-Mora C, Testerman TL, Liu H, Whitmire JM, Studeman K, Jia Y, McAvoy TJ, Francis J, Nieroda C, Sardi A, Merrell DS, Dubois A., “Antibiotic treatment decreases microbial burden associated with pseudomyxoma peritonei and affects β-catenin distribution”, Clin Cancer Res., 15;19(14):3966-76, July 2013. Free pdf link

Gilbreath JJ, Semino-Mora C, Friedline CJ, Liu H, Bodi KL, McAvoy TJ, Francis J, Nieroda C, Sardi A, Dubois A, Lazinski DW, Camilli A, Testerman TL, Merrell DS, “A core microbiome associated with the peritoneal tumors of pseudomyxoma peritonei”, Orphanet J Rare Dis., 12;8:105, July 2013. Free pdf link

Lo AS, Merrell DS, Lei H, Sardi A, McAvoy T, Testerman TL, “A Novel Member of Chitinophagaceae Isolated from a Human Peritoneal Ttumor”, Genome Announc. 12;3(6). pii: e01297-15, Nov. 2015. Free pdf link

Merrell DS, McAvoy T, King MC, Sittig M. Millar EV. Nieroda C, Metcalf JL, Blum FC, Testerman TL, Sardi A, “Pre- and post-operative antibiotics in conjunction with cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC) should be considered for pseudomyxoma peritonei (PMP) treatment”, European Journal of Surgical Oncology,  45(9):1723-1726, Sep. 2019. To purchase a copy go to this link